Restrictions on maternity ward visits: current situation, challenges and recommendations in Auvergne-Rhône-Alpes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study examines current visiting policies in maternity wards and aims to identify challenges and recommendations to improve postpartum care. It uses psychological assessment to understand how policies influence maternal mental health and newborn well-being. Researchers collaborate with CH Annecy Genevois and GIRCI AuRA to analyze practice patterns and propose evidence-informed improvements. Eligible participants are postpartum women with a newborn, staying at least 48 hours, who can consent and communicate in French. The study is conducted in the CH Annecy Genevois facilities in Auvergne‑Rhône‑Alpes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult female patient (aged 18 or over),
* Female patient admitted to the maternity ward with her newborn baby or babies,
* Length of stay in the maternity ward of 48 hours or more,
* Female patient who has been informed about the study and has given her free, informed verbal consent to participate in the study.

Exclusion Criteria:

* Patients who have already participated in this study,
* Patients whose newborn(s) are hospitalised in neonatal units, neonatal intensive care units or neonatal resuscitation units,
* Patients who have given birth to three or more newborns (triplets or more),
* Patient whose newborn(s) has/have died,
* Patient unable to understand spoken or written French, making self-assessment impossible,
* Patient under guardianship, curatorship or placed under judicial protection,
* Patient not covered by the French social security system.

Where it's running

• Centre Hospitalier Annecy Genevois
  Annecy, France Recruiting
• CH Annecy Genevois
  Épagny, Auvergne-Rhône-Alpes, France Not yet recruiting

Study contacts

• Principal investigator: Noëllie FANTINATO, Midwife — Centre Hospitalier Annecy Genevois
• Study coordinator: Marion Beucher, PhD
• Email: mbeucher@ch-annecygenevois.fr
• Phone: +33450637032

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MOM-CARE: enhanced micronutrient supplements during and after pregnancy to help babies be born healthier and grow better

  This will test whether an enhanced multivitamin supplement (MMS Plus) given during pregnancy and after birth helps babies born to women in peri-urban Karachi have better birth outcomes and faster early growth than standard MMS or iron/folic acid.

  Recruiting Phase 3 Aga Khan University · Karachi, Sindh · NCT07029282

• Preventing blood clots in postpartum women at intermediate risk

  This study is testing if giving a blood thinner to women at risk of blood clots after giving birth can help prevent those clots during the first six weeks postpartum.

  Recruiting at 2 sites Phase 4 University Hospital, Brest · Amiens and 17 other locations · NCT06845423

• Investigating fetal cell receptors in postpartum women with skin ulcers

  This study is testing whether fetal cells found in the blood of new mothers with skin ulcers can help heal their wounds better than current treatments.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, Île-de-France Region · NCT06031714

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.